Literature DB >> 28385860

Reducing the burden of lower respiratory tract infections in infants in the Canadian Arctic.

Ian Mitchell, Delshani Peiris.   

Abstract

Entities:  

Year:  2017        PMID： 28385860      PMCID： PMC5367989          DOI： 10.1503/cmaj.161293

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Letters to the Editor.

Authors:  I Mitchell; B Paes; K Lanctot; Rupesh Chawla; Aaron Chiu; Marianna Mitchell; Cecil Ojah; April Price; Sandra Seigel; Amanda Symington
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

2.  Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.

Authors:  Anna Banerji; Kaspar Ng; Theo J Moraes; Vladimir Panzov; Joan Robinson; Bonita E Lee
Journal:  CMAJ Open       Date:  2016-10-18

3.  CARESS: the Canadian registry of palivizumab.

Authors:  Ian Mitchell; Bosco A Paes; Abby Li; Krista L Lanctôt
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

4.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

5.  Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

Authors:  Anna Banerji; Val Panzov; Michael Young; Joan Robinson; Bonita Lee; Theo Moraes; Muhammad Mamdani; B Louise Giles; Depeng Jiang; Danny Bisson; Marguerite Dennis; Johanne Morel; Judith Hall; Charles Hui; Bosco Paes; James B Mahony
Journal:  CMAJ Open       Date:  2016-10-17

6.  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors: 
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

7.  Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.

Authors:  Timothy F Feltes; Allison K Cabalka; H Cody Meissner; Franco M Piazza; David A Carlin; Franklin H Top; Edward M Connor; Henry M Sondheimer
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Palivizumab Adherence and Outcomes in Canadian Aboriginal Children.

Authors:  Charles Hui; Bosco Paes; Jesse Papenburg; Ian Mitchell; Abby Li; Krista L Lanctôt
Journal:  Pediatr Infect Dis J       Date:  2016-11       Impact factor: 2.129

9.  Differences in admission rates of children with bronchiolitis by pediatric and general emergency departments.

Authors:  David W Johnson; Carol Adair; Rollin Brant; Joanne Holmwood; Ian Mitchell
Journal:  Pediatrics       Date:  2002-10       Impact factor: 7.124
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.